nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Angiogenic factors and inflammation in steroid-refractory acute graft-vs-host disease
|
Holtan, Shernan G. |
|
2016 |
167 |
1 |
p. 80-87 8 p. |
artikel |
2 |
Anti-inflammatory interventions—what has worked, not worked, and what may work in the future
|
Fattahi, Fatemeh |
|
2016 |
167 |
1 |
p. 1-6 6 p. |
artikel |
3 |
Author Guidelines
|
|
|
2016 |
167 |
1 |
p. A4-A6 nvt p. |
artikel |
4 |
Autoimmune disease and vaccination: impact on infectious disease prevention and a look at future applications
|
McKinnon, John E. |
|
2016 |
167 |
1 |
p. 46-60 15 p. |
artikel |
5 |
Contents
|
|
|
2016 |
167 |
1 |
p. OBC- 1 p. |
artikel |
6 |
Contents
|
|
|
2016 |
167 |
1 |
p. IFC- 1 p. |
artikel |
7 |
Editorial Advisory Board
|
|
|
2016 |
167 |
1 |
p. A2-A3 nvt p. |
artikel |
8 |
Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges
|
Saxena, Amit |
|
2016 |
167 |
1 |
p. 152-166 15 p. |
artikel |
9 |
Inflammatory targets of therapy in sickle cell disease
|
Owusu-Ansah, Amma |
|
2016 |
167 |
1 |
p. 281-297 17 p. |
artikel |
10 |
Information for Readers
|
|
|
2016 |
167 |
1 |
p. IBC- 1 p. |
artikel |
11 |
Innate inflammation in type 1 diabetes
|
Cabrera, Susanne M. |
|
2016 |
167 |
1 |
p. 214-227 14 p. |
artikel |
12 |
Interferon regulatory factor 5 in human autoimmunity and murine models of autoimmune disease
|
Eames, Hayley L. |
|
2016 |
167 |
1 |
p. 167-182 16 p. |
artikel |
13 |
Masthead
|
|
|
2016 |
167 |
1 |
p. A1- 1 p. |
artikel |
14 |
Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction
|
Khodabandehloo, Hadi |
|
2016 |
167 |
1 |
p. 228-256 29 p. |
artikel |
15 |
Pathway-based approaches to the treatment of inflammatory bowel disease
|
Bamias, Giorgos |
|
2016 |
167 |
1 |
p. 104-115 12 p. |
artikel |
16 |
Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease
|
Durham, Andrew L. |
|
2016 |
167 |
1 |
p. 192-203 12 p. |
artikel |
17 |
Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidence
|
Federico, Alessandro |
|
2016 |
167 |
1 |
p. 116-124 9 p. |
artikel |
18 |
Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation
|
Ryter, Stefan W. |
|
2016 |
167 |
1 |
p. 7-34 28 p. |
artikel |
19 |
Targeting inflammation in metabolic syndrome
|
Welty, Francine K. |
|
2016 |
167 |
1 |
p. 257-280 24 p. |
artikel |
20 |
Targeting inflammation in the prevention of cardiovascular disease in patients with inflammatory arthritis
|
Shen, Jiayun |
|
2016 |
167 |
1 |
p. 138-151 14 p. |
artikel |
21 |
Targeting the inflammasome in rheumatic diseases
|
McCoy, Sara S. |
|
2016 |
167 |
1 |
p. 125-137 13 p. |
artikel |
22 |
Therapeutics targeting inflammation in the immune reconstitution inflammatory syndrome
|
Shahani, Lokesh |
|
2016 |
167 |
1 |
p. 88-103 16 p. |
artikel |
23 |
Therapeutics targeting innate immune/inflammatory responses through the interleukin-6/JAK/STAT signal transduction pathway in patients with cancer
|
Roxburgh, Campbell S.D. |
|
2016 |
167 |
1 |
p. 61-66 6 p. |
artikel |
24 |
Therapeutics targeting persistent inflammation in chronic kidney disease
|
Machowska, Anna |
|
2016 |
167 |
1 |
p. 204-213 10 p. |
artikel |
25 |
Therapeutics targeting the inflammasome after central nervous system injury
|
de Rivero Vaccari, Juan Pablo |
|
2016 |
167 |
1 |
p. 35-45 11 p. |
artikel |
26 |
Therapeutic targeting of acute lung injury and acute respiratory distress syndrome
|
Standiford, Theodore J. |
|
2016 |
167 |
1 |
p. 183-191 9 p. |
artikel |
27 |
Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer
|
Santhanam, Srikanth |
|
2016 |
167 |
1 |
p. 67-79 13 p. |
artikel |